US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors

Istituto Ortopedico Rizzoli

Status: Completed

Conditions: Soft Tissue Sarcoma; Soft Tissue Neoplasm; Soft Tissue Lesion; Soft Tissue Mass

Study type: Observational

Funder types: Other

Identifiers

NCT03452644

Softbiopsy@IOReco

Details and patient eligibility

About

A retrospective evaluation of soft tissue tumors that have undergone core needle biopsy with US guidance (US-CNB)

Full description

The present study is designed to be the first step in the creation of an interdisciplinary platform collecting data on patients and procedures to provide a predictive tool to help physicians in the management of patients affected by a soft tissue lesion.

The primary aim of our work is to evaluate the diagnostic yield of US-CNB. The secondary aim is to exploit all the imaging data conventionally available at a Sarcoma Center before a biopsy on a soft tissue mass, to build a multiparametric model and score of prediction of malignancy, and eventually of biological behavior - grading.

Enrollment: 350 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergone US-CNB for soft tissue lesions at the Rizzoli Orthopaedic Institute

Exclusion criteria

• Patients whose histological diagnosis is not available